Most Recent
Optus has lodged an appeal of a judgment that found the teleco could not claim legal professional privilege to shield from a class action a report by consulting giant Deloitte into last year's major data breach.
Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and failed to revoke two Bayer patents for the drug.
Accounting firm KPMG has asked the High Court for a second time to weigh in on the relevance of a contingency fee order made in a Victoria Supreme Court class action to its bid to transfer the case to NSW.
A union has partially won a bid to exclude thousands of current and former members from a class action against McDonald’s, after losing a challenge that sought to ban all Fair Work group proceedings.
Qantas has been found guilty of a safety violation for standing down a worker who raised concerns about unsafe work conditions during the early days of the coronavirus pandemic.
A judge overseeing a class action against Optus has said there is scope for the teleco to seek redactions of portions of a Deloitte report, which he ruled last Friday failed the test for protection under legal professional privilege.
Optus has lost its fight to keep a class action from accessing an independent report by consulting giant Deloitte into last year's major data breach.
South Australian MP Rebekha Sharkie has asked a court to throw out a "misconceived" lawsuit by a former staffer accusing her of bullying, saying she is not an 'employer' under the Fair Work Act.
Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.
EnergyAustralia has hit back at a lawsuit by Australian parents accusing it of misleading customers, saying it was "valid" to market its products involving a carbon offset scheme as 'carbon neutral'.